Exicure, Inc. (NASDAQ:XCUR) Sees Large Drop in Short Interest

Exicure, Inc. (NASDAQ:XCUR) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 151,700 shares, a decrease of 16.0% from the March 31st total of 180,600 shares. Based on an average daily trading volume, of 213,100 shares, the days-to-cover ratio is presently 0.7 days. Approximately 2.0% of the shares of the stock are sold short.

Exicure Trading Down 1.7 %

Shares of NASDAQ XCUR opened at $0.50 on Monday. The firm’s 50-day moving average price is $0.61 and its 200-day moving average price is $0.60. The stock has a market capitalization of $4.33 million, a price-to-earnings ratio of 0.30 and a beta of 1.31. Exicure has a 12-month low of $0.36 and a 12-month high of $1.50.

Insider Activity

In other news, major shareholder Co. Ltd. Dgp sold 3,400,000 shares of the company’s stock in a transaction dated Thursday, February 29th. The shares were sold at an average price of $1.32, for a total transaction of $4,488,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 3.90% of the company’s stock.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.